Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name BI 882370
Trade Name
Synonyms XP-102|BI-882370|BI882370|XP 102|XP102
Drug Descriptions

BI 882370 is a Raf kinase inhibitor with potent activity against the inactive conformation of Braf and may result in tumor regression (PMID: 26916115).

DrugClasses BRAF Inhibitor 25 RAF Inhibitor (Pan) 28
CAS Registry Number 1392429-79-6
NCIT ID C187123

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Afatinib + BI 882370 Afatinib BI 882370 1 0
BI 882370 BI 882370 0 1
BI 882370 + Cetuximab BI 882370 Cetuximab 1 0
BI 882370 + Trametinib BI 882370 Trametinib 2 1


Additional content available in CKB BOOST